Based on the key indicators related to Vanda Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Vanda Pharmaceuticals may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. At present, Vanda Pharmaceuticals' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 96.8 M, whereas Short and Long Term Debt Total is forecasted to decline to about 9.6 M. Key indicators impacting Vanda Pharmaceuticals' financial strength include:
The essential information of the day-to-day investment outlook for Vanda Pharmaceuticals includes many different criteria found on its balance sheet. An individual investor should monitor Vanda Pharmaceuticals' cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Vanda Pharmaceuticals.
Please note, the presentation of Vanda Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Vanda Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Vanda Pharmaceuticals' management manipulating its earnings.
Vanda Pharmaceuticals Stock Summary
Vanda Pharmaceuticals competes with Biomarin Pharmaceutical, Vaxcyte, Liquidia Technologies, Legend Biotech, and Bio Techne. Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. Vanda Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Washington, the District of Columbia. Vanda Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 278 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Comparative valuation techniques use various fundamental indicators to help in determining Vanda Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Vanda Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vanda Pharmaceuticals competition to find correlations between indicators driving Vanda Pharmaceuticals's intrinsic value. More Info.
Vanda Pharmaceuticals is rated third in return on equity category among its peers. It is rated third in return on asset category among its peers . At present, Vanda Pharmaceuticals' Return On Equity is projected to increase slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Vanda Pharmaceuticals' earnings, one of the primary drivers of an investment's value.
Vanda Pharmaceuticals Systematic Risk
Vanda Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Vanda Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Vanda Pharmaceuticals correlated with the market. If Beta is less than 0 Vanda Pharmaceuticals generally moves in the opposite direction as compared to the market. If Vanda Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Vanda Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Vanda Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Vanda Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Vanda Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Vanda Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Vanda Pharmaceuticals growth as a starting point in their analysis.
Price Earnings To Growth Ratio
0.0164
At present, Vanda Pharmaceuticals' Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting.
Vanda Pharmaceuticals March 24, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Vanda Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Vanda Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Vanda Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Vanda Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Vanda Pharmaceuticals's daily price indicators and compare them against related drivers.
When running Vanda Pharmaceuticals' price analysis, check to measure Vanda Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vanda Pharmaceuticals is operating at the current time. Most of Vanda Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vanda Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vanda Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vanda Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.